A detailed history of Smartleaf Asset Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 392 shares of NBIX stock, worth $49,623. This represents 0.01% of its overall portfolio holdings.

Number of Shares
392
Previous 141 178.01%
Holding current value
$49,623
Previous $18.9 Million 138.17%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$114.58 - $153.15 $28,759 - $38,440
251 Added 178.01%
392 $45.1 Million
Q2 2024

Aug 13, 2024

BUY
$130.86 - $143.19 $12,300 - $13,459
94 Added 200.0%
141 $18.9 Million
Q1 2024

Oct 07, 2024

SELL
$130.4 - $143.74 $12,257 - $13,511
-94 Reduced 66.67%
47 $6.48 Million
Q1 2024

May 02, 2024

BUY
$130.4 - $143.74 $5,737 - $6,324
44 Added 1466.67%
47 $1.72 Million
Q4 2023

Feb 12, 2024

BUY
$106.07 - $132.76 $318 - $398
3 New
3 $0

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.